Prognostic value of quality of life scores in terminal cancer patients

Journal of Pain and Symptom Management

Volumn 11, Issue 1, 1996, Pages 32-41

  Tamburini, Marcello ^a   Brunelli, Cinzia ^a   Rosso, Stefano ^b   Ventafridda, Vittorio ^c  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Piedmont Cancer Registry   (Italy)

^c Floriani Foundation   (Italy)

Author keywords

Assessment; palliative care; prognostic factors; questionnaire

Indexed keywords

ADULT; AGED; ANOREXIA; ARTICLE; CANCER; CANCER SURVIVAL; COGNITION; CONFUSION; EMOTION; FATIGUE; FEMALE; FUNCTIONAL DISEASE; GASTROINTESTINAL SYMPTOM; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALAISE; MALE; MUSCLE WEAKNESS; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; SELF EVALUATION; TERMINAL DISEASE;

EID: 0030059667     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/0885-3924(95)00135-2     Document Type: Article

References (45)

1. Hampe SO. Needs of the grieving spouse in a hospital setting. Nurs Res 1975;24:113-120.
2. Wanzen SH, Adelstein SJ, Cranford RE, et al. The physician's responsibility toward hopelessly ill patients. N Engl J Med 1984;310:955-959.
3. Addington-Hall JM, MacDonald LD, Anderson HR. Can the Spitzer Quality of Life Index help to reduce prognostic uncertainty in terminal care? Br J Cancer 1990;62:695-699.
4. Evans C, McCarthy M. Prognostic uncertainty in terminal care: can the Karnofsky index help? Lancet 1985;1:1204-1206.
5. Forster LE, Lynn J. Predicting life span for applicants to inpatient hospice. Arch Intern Med 1988;148:2540-2543.
6. Heyse-Moore LH, Johnson-Bell VE. Can doctors accurately predict the life expectancy of patients with terminal cancer? Palliat Med 1987;1:165-166.
7. Parkes CM. Accuracy of predictions of survival in later stages of cancer. BMJ 1972;2:29-31.
8. Cohen MH, Makuch R, Johnston-Early A, et al. Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer. Cancer Treat Rep 1981;65:187-195.
9. Thorogood J, Bulman AS, Collins T, Ash D. The use of discriminant analysis to guide palliative treatment for lung cancer patients. Clin Oncol 1992;4:22-26.
10. Shoenfeld Y, Tal A, Berliner S, Pinkhas J. Leukocytosis in nonhematological malignancies: a possible tumor-associated marker. J Cancer Res Clin Oncol 1986;111:54-58.
11. Ventafridda V, De Conno F, Saita L, Ripamonti C, Baronzio GF. Leucocyte-lymphocyte ratio as prognostic indicator of survival in cachectic cancer patients. Ann Oncol 1991;2:196.
12. Fulop T, Hermann F, Rapin CM. Prognostic role of serum albumin and prealbumin levels in elderly patients at admission to a geriatric hospital. Arch Gerontol Geriatr 1991;12:31-39.
13. Hermann FR, Safran C, Levkoff SF, Kenneth I. Serum albumin level on admission as a predictor of death, length of stay and readmission. Arch Intern Med 1992;152:125-130.
14. Ralston ST, Gallacher SJ, Patel U, Campbell J, Boyle IT. Cancer-associated hypercalcemia: morbidity and mortality, clinical experience in 126 treated patients. Ann Intern Med 1990;122:499-504.
15. Rosenthal MA, Gebski VJ, Kefford RF, Stuart-Harris RC. Prediction of life-expectancy in hospice patients: identification of novel prognostic factors. Palliat Med 1993;7:199-204.
16. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948;1:634-656.
17. Bruera E, Miller MJ, Kuehn N, MacEachern T, Hanson J. Estimate of survival of patients admitted to a palliative care unit: a prospective study. J Pain Symptom Manage 1992;7:82-86.
18. Hutchinson TA, Boyd NF, Feinstein AR, Gonda A, Hollomby D, Rowat B. Scientific problems in clinical scales, as demonstrated in the Karnofsky index of performance status. J Chron Dis 1979;32:661-666.
19. Krech RL, Walsh D. Symptoms of pancreatic cancer. J Pain Symptom Manage 1991;6:360-367.
20. Maltoni M, Nanni O, Derni S, et al. Clinical prediction of survival is more accurate than the Karnofsky performance status in estimating life span of terminally ill cancer patients. Eur J Cancer 1994,30A:764-766.
21. Miller RJ. Predicting survival in the advanced cancer patient. Henry Ford Hosp Med J 1991;39:81-84.
22. Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky performance status scale: an examination of its reliability and validity in a research setting. Cancer 1984;53:2002-2007.
23. Morris JN, Suissa S, Sherwood S, Wright SM, Greer D. Last days: a study of the quality of life of terminally ill cancer patients. J Chron Dis 1986;39:47-62.
24. Yates JW, Chalmer B, McKegney P. Evaluation of patients with advanced cancer using the Karnofsky performance status scale. Cancer 1980;45:2220-2224.
25. Hardy JR, Turner R, Saunders M, A'Hern R. Prediction of survival in a hospital-based continuing care unit. Eur J Cancer 1994;30A:284-288.
26. McKegney FP, Bailey L, Yates J. Prediction and management of pain in patients with advanced cancer. Gen Hosp Psychiatry 1981;3:95-101.
27. Reuben DB, Mor V. Dyspnea in terminally ill cancer patients. Chest 1986;89:234-236.
28. Reuben DB, Mor V, Hiris J. Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med 1988;148:1586-1591.
29. Higginson I, McCarthy M. Measuring symptoms in terminal cancer: are pain and dispnoea controlled? J R Soc Med 1989;82:264-267.
30. Ventafridda V, Ripamonti C, Tamburini M. Unendurable symptoms as prognostic indicators of impending death in terminal cancer patients. Eur J Cancer 1990;26:1000-1001.
31. Spitzer OW, Dobson AJ, Hall J, et al. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chron Dis 1981;34:585-597.
32. Coates A, Gebski V, Bishop JF, et al., for the ANZ Breast Cancer Trials Group. Improving the quality of life during chemotherapy for advanced breast cancer: a comparison of intermittent and continuous treatment strategies. N Engl J Med 1987;317:1490-1495.
33. Coates A, Gebski V, Signorini D, et al. Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. J Clin Oncol 1992;10:1833-1838.
34. Priestman T, Baum M, Jones V, Forbes J. Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer. BMJ 1977;1:1248-1250.
35. Ganz PA, Lee JJ, Siau J. Quality of life assessment: an independent prognostic variable for survival in lung cancer. Cancer 1991;67:3131-3135.
36. Kaasa S, Mastekaasa A, Lund E. Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease: the importance of patients' subjective experience of disease and psychosocial well-being. Radiol Oncol 1989;15:235-242.
37. Loprinzi CL, Laurie JA, Wieand HS, et al. Prospective evaluation of prognostic variables from patient-completed questionnaires. J Clin Oncol 1994;12:601-607.
38. Ruckdeschel JC, Piantadosi S, and the Lung Cancer Study Group. Quality of life assessment in lung surgery for bronchogenic carcinoma. Theor Surg 1991;6:201-205.
39. Coates A, Thomson D, McLeod GRM, et al. Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. Eur J Cancer 1993;29A:1731-1734.
40. Tamburini M, Rosso S, Gamba A, Mencaglia E, De Conno F, Ventafridda V. A therapy impact questionnaire for quality-of-life assessment in advanced cancer research. Ann Oncol 1992;3:565-570.
41. Ventafridda V, De Conno F, Ripamonti C, et al. Quality-of-life assessment during a palliative care programme. Ann Oncol 1990;1:415-420.
42. Metha CR, Patel NR. A network algorithm for performing Fisher's exact test in r xc contingency tables. J Am Stat Assoc 1983;78:427-434.
43. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
44. Gehan EA. A generalized Wilcoxon test for comparing arbitrarily singly censored samples. Biometrika 1965;52:203-223.
45. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall, 1984.